Cellebrite Financial Statements From 2010 to 2026

CLBT Stock  USD 17.84  0.19  1.05%   
Analyzing historical trends in various income statement and balance sheet accounts from Cellebrite's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cellebrite's valuation are summarized below:
Gross Profit
382.8 M
Profit Margin
0.1674
Market Capitalization
4.4 B
Enterprise Value Revenue
8.5621
Revenue
455.9 M
There are currently one hundred twenty fundamental signals for Cellebrite DI that can be evaluated and compared over time across rivals. All traders should validate Cellebrite's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 1.8 B in 2026. Enterprise Value is likely to drop to about 1.7 B in 2026

Cellebrite Total Revenue

295.16 Million

Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 5.9 M, Interest Income of 18.8 M or Depreciation And Amortization of 8.6 M, as well as many indicators such as Price To Sales Ratio of 8.22, Dividend Yield of 0.0818 or PTB Ratio of 21.73. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
  
Build AI portfolio with Cellebrite Stock
Check out the analysis of Cellebrite Correlation against competitors.

Cellebrite Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets478.7 M794.2 M376.8 M
Slightly volatile
Other Current Liabilities47.1 M71.2 M34.1 M
Slightly volatile
Total Current Liabilities220.4 M339.8 M156.2 M
Slightly volatile
Other Liabilities109.7 M128 M61.7 M
Slightly volatile
Property Plant And Equipment Net25.4 M31.7 M19.3 M
Slightly volatile
Current Deferred Revenue159 M250.3 M112 M
Slightly volatile
Accounts PayableM12.7 M6.6 M
Slightly volatile
Cash150.3 M220.4 M110.6 M
Slightly volatile
Non Current Assets Total87.9 M141.4 M51.4 M
Slightly volatile
Non Currrent Assets Other4.6 M8.8 M2.5 M
Slightly volatile
Cash And Short Term Investments284.8 M514.3 M244.4 M
Slightly volatile
Net Receivables76.3 M94.7 M58 M
Slightly volatile
Common Stock Shares Outstanding207.3 M240.9 M192 M
Slightly volatile
Short Term Investments308.6 M293.9 M144.1 M
Slightly volatile
Liabilities And Stockholders Equity478.7 M794.2 M376.8 M
Slightly volatile
Non Current Liabilities Total50.5 M53.1 M124.7 M
Pretty Stable
Inventory8.1 M10.3 M5.8 M
Slightly volatile
Other Current Assets24 M33.4 M18.2 M
Slightly volatile
Total Liabilities388.3 M407.7 M288.6 M
Slightly volatile
Property Plant And Equipment Gross48 M77.8 M37.2 M
Slightly volatile
Total Current Assets393.2 M652.7 M326.3 M
Slightly volatile
Accumulated Other Comprehensive Income1.3 M2.4 M1.1 M
Slightly volatile
Non Current Liabilities Other7.6 MM21.3 M
Slightly volatile
Net Working Capital172.8 M312.9 M170.2 M
Slightly volatile
Property Plant Equipment22.2 M37.8 M20 M
Slightly volatile
Intangible Assets11.2 M13 M8.3 M
Slightly volatile
Short and Long Term Debt Total10.8 M9.9 M14.4 M
Slightly volatile
Short Term Debt3.8 M3.7 M4.8 M
Slightly volatile

Cellebrite Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income18.8 M21 M9.9 M
Slightly volatile
Depreciation And Amortization8.6 M12.2 M6.1 M
Slightly volatile
Interest Expense422.3 M402.2 M69.4 M
Slightly volatile
Selling General Administrative44.3 M58.5 M35.4 M
Slightly volatile
Selling And Marketing Expenses99 M152.2 M79.2 M
Slightly volatile
Total Revenue295.2 M461.4 M230.2 M
Slightly volatile
Gross Profit243.3 M389.4 M187.3 M
Slightly volatile
Other Operating Expenses274.5 M395.9 M219.3 M
Slightly volatile
Research Development78.8 M113.2 M61.2 M
Slightly volatile
Cost Of Revenue51.9 M72 M42.9 M
Slightly volatile
Total Operating Expenses222.6 M324 M176.4 M
Slightly volatile
Reconciled Depreciation8.6 M12.2 M6.1 M
Slightly volatile

Cellebrite Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation36.9 M35.2 M16.3 M
Slightly volatile
Free Cash Flow146.8 M139.8 M41.3 M
Slightly volatile
Begin Period Cash Flow123.8 M217.9 M79.3 M
Slightly volatile
Other Cashflows From Financing Activities25.4 M18.6 M67.5 M
Slightly volatile
Depreciation8.6 M12.2 M6.1 M
Slightly volatile
Capital Expenditures8.8 M12.2 M7.4 M
Slightly volatile
Total Cash From Operating Activities159.6 M152 M48.8 M
Slightly volatile
End Period Cash Flow152.2 M220.4 M114 M
Slightly volatile
Change To Liabilities33.7 M38.5 M24.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.2213.239.4688
Slightly volatile
Dividend Yield0.08180.07790.0382
Slightly volatile
Days Sales Outstanding10786.1795.6071
Very volatile
Free Cash Flow Yield0.02110.02370.0148
Slightly volatile
Operating Cash Flow Per Share0.60.570.2305
Slightly volatile
Stock Based Compensation To Revenue0.04310.06860.0649
Slightly volatile
Capex To Depreciation1.191.151.3257
Slightly volatile
EV To Sales7.6812.718.9968
Slightly volatile
Free Cash Flow Per Share0.550.520.1915
Slightly volatile
ROIC0.140.130.0434
Slightly volatile
Inventory Turnover7.58.058.1094
Slightly volatile
Days Of Inventory On Hand44.7346.9146.4855
Slightly volatile
Payables Turnover7.746.56.8604
Pretty Stable
Sales General And Administrative To Revenue0.170.150.1614
Slightly volatile
Research And Ddevelopement To Revenue0.30.280.2728
Pretty Stable
Capex To Revenue0.0340.03040.0338
Slightly volatile
Cash Per Share1.111.921.2349
Slightly volatile
POCF Ratio48.3140.1580.0354
Slightly volatile
Capex To Operating Cash Flow0.08770.09230.2909
Slightly volatile
PFCF Ratio69.8443.66126
Slightly volatile
Days Payables Outstanding44.8858.1354.7716
Very volatile
EV To Operating Cash Flow45.1338.5876.2249
Slightly volatile
EV To Free Cash Flow65.3141.95120
Slightly volatile
Intangibles To Total Assets0.08330.06660.057
Slightly volatile
Current Ratio2.052.212.3045
Slightly volatile
Receivables Turnover3.064.383.8465
Very volatile
Debt To Equity0.03570.03750.1895
Slightly volatile
Capex Per Share0.03530.04560.0379
Slightly volatile
Revenue Per Share1.171.721.1723
Slightly volatile
Interest Debt Per Share1.631.550.338
Slightly volatile
Debt To Assets0.02950.01830.0344
Slightly volatile
Graham Number1.182.211.0914
Slightly volatile
Short Term Coverage Ratios25.6328.8431.476
Slightly volatile
Operating Cycle169146144
Slightly volatile
Days Of Payables Outstanding44.8858.1354.7716
Very volatile
Price To Operating Cash Flows Ratio48.3140.1580.0354
Slightly volatile
Price To Free Cash Flows Ratio69.8443.66126
Slightly volatile
Total Debt To Capitalization0.03450.03640.1548
Slightly volatile
Debt Equity Ratio0.03570.03750.1895
Slightly volatile
Quick Ratio2.02.172.265
Slightly volatile
Dividend Paid And Capex Coverage Ratio11.7711.213.5415
Slightly volatile
Cash Ratio0.770.750.7439
Slightly volatile
Cash Conversion Cycle10771.8387.1345
Slightly volatile
Operating Cash Flow Sales Ratio0.180.30.1545
Slightly volatile
Days Of Inventory Outstanding44.7346.9146.4855
Slightly volatile
Days Of Sales Outstanding10786.1795.6071
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.620.830.6873
Slightly volatile
Cash Flow Coverage Ratios5.510.843.1196
Slightly volatile
Fixed Asset Turnover9.5913.0811.7023
Very volatile
Capital Expenditure Coverage Ratio6.0611.215.063
Slightly volatile
Price Cash Flow Ratio48.3140.1580.0354
Slightly volatile
Debt Ratio0.02950.01830.0344
Slightly volatile
Cash Flow To Debt Ratio5.510.843.1196
Slightly volatile
Price Sales Ratio8.2213.239.4688
Slightly volatile
Asset Turnover0.50.520.6044
Slightly volatile
Gross Profit Margin0.660.760.7918
Pretty Stable

Cellebrite Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.9 B1.8 B
Pretty Stable
Enterprise Value1.7 B1.7 B1.6 B
Slightly volatile

Cellebrite Fundamental Market Drivers

Forward Price Earnings37.1747
Cash And Short Term Investments447.2 M

Cellebrite Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cellebrite Financial Statements

Cellebrite shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue250.3 M159 M
Total Revenue461.4 M295.2 M
Cost Of Revenue72 M51.9 M
Stock Based Compensation To Revenue 0.07  0.04 
Sales General And Administrative To Revenue 0.15  0.17 
Research And Ddevelopement To Revenue 0.28  0.30 
Capex To Revenue 0.03  0.03 
Revenue Per Share 1.72  1.17 
Ebit Per Revenue 0.14  0.13 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.